First-order effects

• Portfolio companies raising on Vision Fund 2's 2021 cadence now face smaller average checks — the same 50-ish deals per quarter are being funded with roughly half the dollars of the Q3 2021 peak.
• SoftBank itself shifts from deploying at a record-setting rate to conserving capital, just before the fund's marks turn sharply negative.

Second-order effects

• Startups that priced late-stage rounds against Vision Fund 2's peak-2021 appetite lose their marginal buyer, pressuring valuations across the growth-stage market the fund anchored.
• Rival growth investors who matched SoftBank's pace in 2021 must decide whether to defend deal flow at falling prices or follow the same retreat, thinning the bid for late-stage private companies.

Third-order effects

• The pattern that follows — a ~$16.4B quarterly loss for the Vision Funds and then a partial recovery tied to Arm rather than new bets — points to mega-funds shifting from deployment-driven returns to managing existing positions.
• If the cycle repeats, the era of a single fund setting the clearing price for growth-stage tech gives way to more fragmented, valuation-disciplined late-stage funding.